Joel Lewis - Net Worth and Insider Trading
Joel Lewis Net Worth
The estimated net worth of Joel Lewis is at least $3 Million dollars as of 2024-11-13. Joel Lewis is the President and CEO of Galectin Therapeutics Inc and owns about 899,012 shares of Galectin Therapeutics Inc (GALT) stock worth over $3 Million. Details can be seen in Joel Lewis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joel Lewis has not made any transactions after 2024-04-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joel Lewis
Joel Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joel Lewis owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Joel Lewis’s form 4 insider trades.
Insider Ownership Summary of Joel Lewis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-04-24 | director |
Joel Lewis Latest Holdings Summary
Joel Lewis currently owns a total of 1 stock. Joel Lewis owns 899,012 shares of Galectin Therapeutics Inc (GALT) as of April 24, 2024, with a value of $3 Million.
Latest Holdings of Joel Lewis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-04-24 | 899,012 | 2.95 | 2,652,085 |
Holding Weightings of Joel Lewis
Joel Lewis Form 4 Trading Tracker
According to the SEC Form 4 filings, Joel Lewis has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 1,000 shares on April 24, 2024, which cost Joel Lewis around $3,390.
Insider Trading History of Joel Lewis
- 1
Joel Lewis Trading Performance
GuruFocus tracks the stock performance after each of Joel Lewis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joel Lewis is -15.7%. GuruFocus also compares Joel Lewis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joel Lewis within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joel Lewis's insider trading performs compared to the benchmark.
Performance of Joel Lewis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.67 | | | | | |
| Relative Return to S&P 500(%) | -7.11 | | | | | |
Joel Lewis Ownership Network
Ownership Network List of Joel Lewis
Ownership Network Relation of Joel Lewis
Joel Lewis Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Joel Lewis is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Joel Lewis made 1 insider transaction in Galectin Therapeutics Inc (GALT) with a net purchase of 1,000. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 15,300 shares, with a net purchase of 15,300 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Joel Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Joel Lewis. You might contact Joel Lewis via mailing address: 12575 Uline Drive, Pleasant Prairie Wi 53158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
